Modeling Challenges in Cost-Effectiveness Analysis of First-Line Immuno-Oncology Therapies in Non-small Cell Lung Cancer: A Systematic Literature Review

INTRODUCTION: The introduction of immuno-oncology (IO) therapies has changed the treatment landscape of non-small cell lung cancer (NSCLC). Numerous cost-effectiveness analyses (CEAs) and technology appraisals (TAs) evaluating IO therapies have been recently published. OBJECTIVE: We reviewed economi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kongnakorn, Thitima, Sarri, Grammati, Freitag, Andreas, Marczell, Kinga, Kazmierska, Paulina, Masters, Elizabeth, Pawar, Vivek, Zhang, Xinke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795065/
https://www.ncbi.nlm.nih.gov/pubmed/34595671
http://dx.doi.org/10.1007/s40273-021-01089-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795065/
https://www.ncbi.nlm.nih.gov/pubmed/34595671
http://dx.doi.org/10.1007/s40273-021-01089-4

Ejemplares similares